固体腫瘍におけるCAR-T細胞の投与と有効性に関する生理学的に基礎づけられた薬理学モデル
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
抗VEGF療法による血管正常化は,腫瘍の微小環境をより支援するので,固体腫瘍に対するCAR- T細胞療法を改善する. このアプローチはT細胞の浸透を促進し,必要なCAR-T細胞の投与量を大幅に減らす.
科学分野:
- 免疫学
- 腫瘍学
- コンピュータ生物学
背景:
- 不正常な腫瘍血管は,腫瘍の微小環境 (TME) でT細胞の有効性を阻害する.
- 抗VEGF療法による血管正常化は,前臨床のグリブラストーマモデルにおけるCAR- T細胞治療結果の改善に有望であることが示された.
研究 の 目的:
- 固体腫瘍の血管後の正常化におけるCAR- T細胞と内生免疫細胞の動態をシミュレートする薬理学モデルを開発する.
- 固体腫瘍の投与量,スケジュール,投与経路を含むCAR-T治療戦略の最適化.
主な方法:
- 生理学的な薬理学モデルを開発する.
- 固体腫瘍におけるCAR-T細胞と内生免疫細胞のダイナミクスのシミュレーション
- TME組成とCAR-T細胞の有効性に対する血管正常化効果の分析
主要な成果:
- 血管の正常化により,TMEは免疫を補強し,CD8+T細胞とCAR-T細胞の浸透を促進します.
- M1マクロファージは増加し,M2マクロファージと調節性T細胞は減少し,有効性が向上する.
- CAR- T細胞の投与量を10倍に減らし,最適のスケジューリングにより抗腫瘍機能が強化される.
結論:
- 固体腫瘍に対するCAR-T細胞治療の強化には,血管の正常化が重要な戦略です.
- 開発されたモデルは,CAR-T療法のパラメータを最適化するための枠組みを提供します.
- 血管とストロマの正常化を組み合わせると,デスマプラスティック腫瘍に利益があり,局所発症は結果を改善することができます.
関連する概念動画
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
79
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
79
01:26Pharmacokinetic Models: Comparison and Selection Criterion
147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
108
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
108
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
01:20Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
91
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
91